Company page

Denali Therapeutics Inc.

Denali Therapeutics Inc. is a public biotechnology company based in the United States, focused on developing therapies for neurodegenerative diseases. The company trades under the ticker DNLI and has a market capitalization of approximately $3.7 billion. Denali is dedicated to advancing its innovative drug candidates through clinical trials to address unmet medical needs in neurology.